Thomas S Uldrick (T Uldrick)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 13

Top Topics

Human Immunodeficiency Virus

Antiretroviral Therapy

Advanced Non Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Ramya Ramaswami, Thomas S Uldrick
Remission after rituximab for HHV8+ MCD: what next? Blood advances 7 (18) (2023)
Thomas A Odeny, Kathryn Lurain, Julius Strauss, Steven P Fling, Elad Sharon, Anna Wright, Javier Martinez-Picado, Teresa Morán, James L Gulley, Maria Gonzales Cao, Thomas S Uldrick, Robert Yarchoan, Ramya Ramaswami
Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer. Journal for immunotherapy of cancer 10 (9) (2023)
Kathryn Lurain, Ramya Ramaswami, Ralph Mangusan, Anaida Widell, Irene Ekwede, Jomy George, Richard Ambinder, Martin Cheever, James L Gulley, Priscila H Goncalves, Hao-Wei Wang, Thomas S Uldrick, Robert Yarchoan
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphoma. Journal for immunotherapy of cancer 9 (2) (2022)
Thomas S Uldrick, Scott V Adams, Remi Fromentin, Michael Roche, Steven P Fling, Priscila H Gonçalves, Kathryn Lurain, Ramya Ramaswami, Chia-Ching Jackie Wang, Robert J Gorelick, Jorden L Welker, Liz O'Donoghue, Harleen Choudhary, Jeffrey D Lifson, Thomas A Rasmussen, Ajantha Rhodes, Carolin Tumpach, Robert Yarchoan, Frank Maldarelli, Martin A Cheever, Rafick-Pierre Sekaly, Nicolas Chomont, Steven G Deeks, Sharon R Lewin
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy. Science translational medicine 14 (629) (2022)
Edward S Kim, Thomas S Uldrick, Caroline Schenkel, Suanna Steeby Bruinooge, Robert Donald Harvey, Allison Magnuson, Alexander Spira, James L Wade, Mark D Stewart, Diana Merino Vega, Julia A Beaver, Andrea M Denicoff, Gwynn Ison, S Percy Ivy, Suzanne George, Raymond P Perez, Patricia A Spears, William D Tap, Richard L Schilsky
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Robert Donald Harvey, Kathryn F Mileham, Vishal Bhatnagar, Jamie R Brewer, Atiqur Rahman, Cassadie Moravek, Andrew S Kennedy, Elizabeth A Ness, E Claire Dees, S Percy Ivy, Scot W Ebbinghaus, Caroline Schenkel, Thomas S Uldrick
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Jason D Goldman, Philip C Robinson, Thomas S Uldrick, Qamar-Un-Nisa Chaudhry
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. Journal for immunotherapy of cancer 9 (6) (2021)
Robert Donald Harvey, Suanna Steeby Bruinooge, Li Chen, Elizabeth Garrett-Mayer, Whitney Rhodes, Edward Stepanski, Thomas S Uldrick, Gwynn Ison, Sean Khozin, Wendy S Rubinstein, Caroline Schenkel, Robert S Miller, George A Komatsoulis, Richard L Schilsky, Edward S Kim
Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non-Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Kathryn Lurain, Ramya Ramaswami, Robert Yarchoan, Thomas S Uldrick
Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer. Current HIV/AIDS reports 17 (5) (2021)
Giorgio Bozzi, Francesco R Simonetti, S A Watters, Elizabeth M Anderson, M Gouzoulis, Mary F Kearney, P Rote, C Lange, W Shao, Robert J Gorelick, B Fullmer, S Kumar, S Wank, Stephen M Hewitt, David E Kleiner, Junko Hattori, M J Bale, S Hill, J Bell, C Rehm, Z Grossman, Robert Yarchoan, Thomas S Uldrick, Frank Maldarelli
No evidence of ongoing HIV replication or compartmentalization in tissues during combination antiretroviral therapy: Implications for HIV eradication. Science advances 5 (9) (2019)
Kathryn Lurain, Mark N Polizzotto, Karen Aleman, Manisha Bhutani, Kathleen M Wyvill, Priscila H Gonçalves, Ramya Ramaswami, Vickie Ann Marshall, Wendell Miley, Seth M Steinberg, Richard F Little, Wyndham Wilson, Armando C Filie, Stefania Pittaluga, Elaine S Jaffe, Denise Whitby, Robert Yarchoan, Thomas S Uldrick
Viral, immunologic, and clinical features of primary effusion lymphoma. Blood 133 (16) (2019)
Thomas S Uldrick
iNKT cell defects in HHV-8-associated MCD. Blood 129 (7) (2018)
Sriram Venneti, Thomas S Uldrick
Primary effusion lymphoma and concurrent progressive Kaposi sarcoma associated with elevated interleukin-6. Blood 127 (23) (2016)